A citation-based method for searching scientific literature

Barbara Nowacka, Wojciech Lubiński, Krystyna Honczarenko, Andrzej Potemkowski, Krzysztof Safranow. Doc Ophthalmol 2015
Times Cited: 24







List of co-cited articles
297 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Electrophysiology and optical coherence tomography to evaluate Parkinson disease severity.
Elena Garcia-Martin, Diego Rodriguez-Mena, Maria Satue, Carmen Almarcegui, Isabel Dolz, Raquel Alarcia, Maria Seral, Vicente Polo, Jose M Larrosa, Luis E Pablo. Invest Ophthalmol Vis Sci 2014
64
45

Retinal nerve fiber layer thinning in Parkinson disease.
Rivka Inzelberg, Jose Antonio Ramirez, Puiu Nisipeanu, Avinoam Ophir. Vision Res 2004
216
45

The retina in Parkinson's disease.
Neil K Archibald, Michael P Clarke, Urs P Mosimann, David J Burn. Brain 2009
213
41

Retinal nerve fiber layer thickness and visual hallucinations in Parkinson's Disease.
Jee-Young Lee, Jae Min Kim, Jeeyun Ahn, Han-Joon Kim, Beom S Jeon, Tae Wan Kim. Mov Disord 2014
69
41

Decreased dopamine in the retinas of patients with Parkinson's disease.
C Harnois, T Di Paolo. Invest Ophthalmol Vis Sci 1990
241
41

Correlation of inner retinal thickness evaluated by spectral-domain optical coherence tomography and contrast sensitivity in Parkinson disease.
Christopher R Adam, Eric Shrier, Yin Ding, Sofya Glazman, Ivan Bodis-Wollner. J Neuroophthalmol 2013
59
37

Alteration of visual evoked potentials and electroretinograms in Parkinson's disease.
I Gottlob, E Schneider, W Heider, W Skrandies. Electroencephalogr Clin Neurophysiol 1987
96
37


α-synuclein in the inner retina in parkinson disease.
Ivan Bodis-Wollner, Piotr B Kozlowski, Sofya Glazman, Shahnaz Miri. Ann Neurol 2014
92
37

Phosphorylated α-synuclein-immunoreactive retinal neuronal elements in Parkinson's disease subjects.
Thomas G Beach, Jeremiah Carew, Geidy Serrano, Charles H Adler, Holly A Shill, Lucia I Sue, Marwan N Sabbagh, Haruhiko Akiyama, Nicolás Cuenca. Neurosci Lett 2014
76
37

Visual dysfunction in Parkinson's disease.
Rimona S Weil, Anette E Schrag, Jason D Warren, Sebastian J Crutch, Andrew J Lees, Huw R Morris. Brain 2016
163
37

Interocular asymmetry of foveal thickness in Parkinson disease.
Eric M Shrier, Christopher R Adam, Brian Spund, Sofya Glazman, Ivan Bodis-Wollner. J Ophthalmol 2012
49
33


Dopamine and retinal function.
Paul Witkovsky. Doc Ophthalmol 2004
501
33

Venturing into the no-man's land of the retina in Parkinson's disease.
Ivan Bodis-Wollner, Shahnaz Miri, Sofya Glazman. Mov Disord 2014
45
29

The retina as a window to the brain-from eye research to CNS disorders.
Anat London, Inbal Benhar, Michal Schwartz. Nat Rev Neurol 2013
423
29

A combination of retinal morphology and visual electrophysiology testing increases diagnostic yield in Parkinson's disease.
Shahnaz Miri, Sofya Glazman, Leland Mylin, Ivan Bodis-Wollner. Parkinsonism Relat Disord 2016
27
29

Visual contrast response functions in Parkinson's disease: evidence from electroretinograms, visually evoked potentials and psychophysics.
T Langheinrich, L Tebartz van Elst, W A Lagrèze, M Bach, C H Lücking, M W Greenlee. Clin Neurophysiol 2000
55
29


Correlation between retinal morphological and functional findings and clinical severity in Parkinson's disease.
Ozgül Altintaş, Pervin Işeri, Berna Ozkan, Yusuf Cağlar. Doc Ophthalmol 2008
151
29

Optical coherence tomography in parkinsonian syndromes.
Philipp Albrecht, Ann-Kristin Müller, Martin Südmeyer, Stefano Ferrea, Marius Ringelstein, Eva Cohn, Orhan Aktas, Thomas Dietlein, Alexandra Lappas, Andreas Foerster,[...]. PLoS One 2012
112
29

[The electroretinogram and visual evoked potentials in patients with Parkinson's disease].
J A Burguera, C Vilela, A Traba, Y Ameave, M Vallet. Arch Neurobiol (Madr) 1990
12
58

Foveal vision is impaired in Parkinson's disease.
Ivan Bodis-Wollner. Parkinsonism Relat Disord 2013
43
29

Inner retinal layer thinning in Parkinson disease.
Mohammedyusuf E Hajee, Wayne F March, Douglas R Lazzaro, Arthur H Wolintz, Eric M Shrier, Sofya Glazman, Ivan G Bodis-Wollner. Arch Ophthalmol 2009
176
25

Distribution of retinal layer atrophy in patients with Parkinson disease and association with disease severity and duration.
Elena Garcia-Martin, Jose M Larrosa, Vicente Polo, Maria Satue, Marcia L Marques, Raquel Alarcia, Maria Seral, Isabel Fuertes, Sofia Otin, Luis E Pablo. Am J Ophthalmol 2014
81
25


Abnormalities in color vision and contrast sensitivity in Parkinson's disease.
M J Price, R G Feldman, D Adelberg, H Kayne. Neurology 1992
171
25

Remodeling of the fovea in Parkinson disease.
B Spund, Y Ding, T Liu, I Selesnick, S Glazman, E M Shrier, I Bodis-Wollner. J Neural Transm (Vienna) 2013
54
25

Does pattern electroretinogram spatial tuning alteration in Parkinson's disease depend on motor disturbances or retinal dopaminergic loss?
A Peppe, P Stanzione, M Pierantozzi, R Semprini, A Bassi, A M Santilli, R Formisano, M Piccolino, G Bernardi. Electroencephalogr Clin Neurophysiol 1998
43
25

Optical coherence tomography in Parkinson's disease: is the retina a biomarker?
Jee-Young Lee, Jeeyun Ahn, Tae Wan Kim, Beom Seok Jeon. J Parkinsons Dis 2014
47
25

Morphologic changes and functional retinal impairment in patients with Parkinson disease without visual loss.
Marilita M Moschos, Georgios Tagaris, Ioannis Markopoulos, Ioannis Margetis, Stylianos Tsapakis, Menelaos Kanakis, Chrysanthi Koutsandrea. Eur J Ophthalmol 2011
105
25

Visual symptoms in Parkinson's disease and Parkinson's disease dementia.
Neil K Archibald, Mike P Clarke, Urs P Mosimann, David J Burn. Mov Disord 2011
112
25

The retina as an early biomarker of neurodegeneration in a rotenone-induced model of Parkinson's disease: evidence for a neuroprotective effect of rosiglitazone in the eye and brain.
Eduardo Maria Normando, Benjamin Michael Davis, Lies De Groef, Shereen Nizari, Lisa A Turner, Nivedita Ravindran, Milena Pahlitzsch, Jonathan Brenton, Giulia Malaguarnera, Li Guo,[...]. Acta Neuropathol Commun 2016
56
25

Phosphorylated α-synuclein in the retina is a biomarker of Parkinson's disease pathology severity.
Isabel Ortuño-Lizarán, Thomas G Beach, Geidy E Serrano, Douglas G Walker, Charles H Adler, Nicolás Cuenca. Mov Disord 2018
59
25

ISCEV Standard for full-field clinical electroretinography (2015 update).
Daphne L McCulloch, Michael F Marmor, Mitchell G Brigell, Ruth Hamilton, Graham E Holder, Radouil Tzekov, Michael Bach. Doc Ophthalmol 2015
802
20

Characterization of retinal architecture in Parkinson's disease.
Jessica Chorostecki, Navid Seraji-Bozorgzad, Aashka Shah, Fen Bao, Ginny Bao, Edwin George, Veronica Gorden, Christina Caon, Elliot Frohman, M Tariq Bhatti,[...]. J Neurol Sci 2015
33
20

Ophthalmological features of Parkinson disease.
Barbara Nowacka, Wojciech Lubinski, Krystyna Honczarenko, Andrzej Potemkowski, Krzysztof Safranow. Med Sci Monit 2014
55
20

Ability and reproducibility of Fourier-domain optical coherence tomography to detect retinal nerve fiber layer atrophy in Parkinson's disease.
Elena Garcia-Martin, Maria Satue, Isabel Fuertes, Sofia Otin, Raquel Alarcia, Raquel Herrero, Maria P Bambo, Javier Fernandez, Luis E Pablo. Ophthalmology 2012
88
20

Alpha synuclein gene expression profile in the retina of vertebrates.
Gema C Martínez-Navarrete, José Martín-Nieto, Julián Esteve-Rudd, Antonia Angulo, Nicolás Cuenca. Mol Vis 2007
57
20

Abnormal visual contrast acuity in Parkinson's disease.
Tanya P Lin, Heather Rigby, Jennifer S Adler, Joseph G Hentz, Laura J Balcer, Steven L Galetta, Steve Devick, Richard Cronin, Charles H Adler. J Parkinsons Dis 2015
27
20

Progressive worsening of spatial and chromatic processing deficits in Parkinson disease.
Nico J Diederich, Rema Raman, Sue Leurgans, Christopher G Goetz. Arch Neurol 2002
89
20

Detection of retinal changes in idiopathic Parkinson's disease using high-resolution optical coherence tomography and heidelberg retina tomography.
Diana Bittersohl, Birthe Stemplewitz, Matthias Keserü, Carsten Buhmann, Gisbert Richard, Andrea Hassenstein. Acta Ophthalmol 2015
24
20


Detection of retinal changes in Parkinson's disease with spectral-domain optical coherence tomography.
Grant D Aaker, Jane S Myung, Joshua R Ehrlich, Mujtaba Mohammed, Claire Henchcliffe, Szilárd Kiss. Clin Ophthalmol 2010
84
20

Visual dysfunction in Parkinson's disease. Loss in spatiotemporal contrast sensitivity.
I Bodis-Wollner, M S Marx, S Mitra, P Bobak, L Mylin, M Yahr. Brain 1987
227
20

Color discrimination deficits in Parkinson's disease are related to cognitive impairment and white-matter alterations.
Josie-Anne Bertrand, Christophe Bedetti, Ronald B Postuma, Oury Monchi, Daphné Génier Marchand, Thomas Jubault, Jean-François Gagnon. Mov Disord 2012
52
20

Visual dysfunction and its correlation with retinal changes in patients with Parkinson's disease: an observational cross-sectional study.
V Polo, M Satue, M J Rodrigo, S Otin, R Alarcia, M P Bambo, M I Fuertes, J M Larrosa, L E Pablo, E Garcia-Martin. BMJ Open 2016
39
20

Retinal thickness in Parkinson's disease.
N K Archibald, M P Clarke, U P Mosimann, D J Burn. Parkinsonism Relat Disord 2011
81
20

Impairment of high-contrast visual acuity in Parkinson's disease.
R D Jones, I M Donaldson, P L Timmings. Mov Disord 1992
50
20

The pattern electroretinogram in Parkinson's disease reveals lack of retinal spatial tuning.
M Tagliati, I Bodis-Wollner, M D Yahr. Electroencephalogr Clin Neurophysiol 1996
71
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.